Molecular prognostic factors in acute myeloid leukemia (AML) receiving first-line therapy with azacitidine
Desoutter, J, Gay, J, Berthon, C, Ades, L, Gruson, B, Geffroy, S, Plantier, I, Alice, M, Helevaut, N, Fernandes, J, Bemba, M, Stalnikiewicz, L, Frimat, C, Labreuche, J, Nibourel, O, Roumier, C, FigeacLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2015.314
Date:
November, 2015
File:
PDF, 868 KB
english, 2015